Abstract The congenital heart disease (CHD) population has seen substantial growth due to advancements in paediatric cardiac care, cardiothoracic surgery, anaesthesia, and intensive care. Although improved surgical interventions have enhanced survival rates for even the most severe defects, such as hypoplastic left heart syndrome, most CHD patients remain palliated rather than cured, requiring lifelong expert care. With increasing survival, new challenges emerge in managing the ageing CHD population, particularly regarding changing medical, psychosocial needs, and the evolving epidemiology of CHD. Imaging plays a pivotal role in CHD care, offering precise anatomical and physiological insights necessary for effective management and risk stratification. The European Association of Cardiovascular Imaging (EACVI) established a shared interest group (SIG) to improve imaging standardisation, promote education, and foster research for CHD patients. Multimodality imaging, including echocardiography, cardiovascular magnetic resonance (CMR), and computed tomography (CT), is critical in guiding interventions and improving outcomes. The SIG also addresses gaps in education, research, and global healthcare disparities, ensuring a collaborative and systematic approach to CHD care. Advances in imaging technology, genetic research, and tissue engineering hold promise for further improving the longevity and quality of life for CHD patients in the future.
Salvo et al. (Tue,) studied this question.